Frank Atlee V - Director, Antigenics Inc

As of June 11, 2007


Frank Atlee V Net Worth

  • Net worth is estimated to be at least $9.68K
  • Sold an estimated value of $9.68K in the last 3 years at Antigenics Inc

Frank Atlee V Trading

  • Largest sale of shares was 4,500 units , worth over $9.68K on November 6, 2006
  • In total has made about 14 transactions over 3 years
  • Usually trades in June and January, with the busiest year in 2006
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Frank Atlee V Mailing Address

  • Mailing address is C/o Monsanto Company 800 N. Lindbergh Blvd. St. Louis MO 63167 MO

Antigenics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Garo H. Armen, Ph.D. 2020 $677,267 $393,000 - $4,563,132 $3,845 $5,637,244
Garo H. Armen, Ph.D. 2019 $634,362 $550,000 $1,910,662 $6,837,849 $4,165 $9,937,038
Garo H. Armen, Ph.D. 2018 $610,471 $525,000 $144,000 $1,284,313 $4,058 $2,567,842
Jennifer Buell, Ph.D. 2020 $483,077 $220,000 - $2,121,987 $4,846 $2,829,910
Jennifer Buell, Ph.D. 2019 $407,613 $275,000 - $1,697,871 - $2,385,369
Jennifer Buell, Ph.D. 2018 $340,692 $250,000 $13,500 $377,560 $4,715 $986,467
Evan D. Kearns 2020 $407,692 $160,000 - $349,978 $5,696 $923,366
Evan D. Kearns 2019 $353,269 $230,000 - $1,021,551 $5,758 $1,610,578
Christine M. Klaskin 2020 $285,166 $72,000 - $144,739 $5,800 $507,705
Adam Krauss 2020 $33,846 - $129,500 $291,317 - $454,663
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1098972/000119312521144952/d238705ddef14a.htm

Antigenics Inc Insider Trading

  • The most recent transaction was 82,107 units sold on September 14, 2021 by Garo H Armen worth over $533.7K
  • In the last 18 years, insiders at Antigenics Inc sold an estimated value of $38.63M and bought an estimated value of $95.89M
  • The most active traders are Garo H Armen, Chairman and CEO,  Wadih Jordan, Director,  and Timothy Wright, Director
  • Insider trading is most common in June, with the busiest year in 2011
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1